• Preface
  • Table of Figures
  • Table of Tables
  • Acknowledgements
  • CHAPTER 1 Executive summary
  • Beau Kilmer, Rosalie Liccardo Pacula and Stijn Hoorens
  • Introduction
  • Key insights
  • Recommendations
  • Closing thoughts
  • CHAPTER 2 Introduction
  • Stijn Hoorens and Beau Kilmer
  • CHAPTER 3 A framework for thinking about drug markets
  • Rosalie Liccardo Pacula, Beau Kilmer and Priscillia Hunt
  • 3.1 Introduction
  • 3.2 Background: an economic framework for thinking about the market for drugs
  • 3.3 Indicators and policy-relevant data for understanding drug markets
  • 3.4 Conclusions and recommendations
  • CHAPTER 4 Indicators for understanding supply-reduction efforts
  • Beau Kilmer, Rosalie Liccardo Pacula, Priscillia Hunt and Lila Rabinovich
  • 4.1 Introduction
  • 4.2 RAND’s framework for supply-side interventions
  • 4.3 Sources of supply and supply-reduction strategies
  • 4.4 Indicators for understanding supply-reduction strategies
  • 4.5 Conclusions
  • CHAPTER 5 Indicators for understanding drug-related crime
  • Emma Disley, Stijn Hoorens, Priscillia Hunt, Beau Kilmer, Rosalie LiccardoPacula, Lila Rabinovich and Jennifer Rubin
  • 5.1 Introduction
  • 5.2 Previous approaches to thinking about drug-related crime
  • 5.3 The RAND framework for thinking about drug-related crime
  • 5.4 Drug-related crime data
  • 5.5 Possible indicators of drug-related crime
  • 5.6 The nature of the association between drugs and crime: A review of the literature
  • 5.7 Generating attribution factors
  • 5.8 Conclusions
  • CHAPTER 6 Insights from three case studies
  • Stijn Hoorens, Susan Kirk, Lila Rabinovich and Emma Disley
  • 6.1 The United Kingdom
  • 6.2 Czech Republic
  • 6.3 Spain
  • 6.4 Conclusions
  • REFERENCES
  • Reference list
  • APPENDICES
  • Appendix A. Creating price series without data: Harnessing the power of forensic data
  • Appendix B. Summary of major publicly-available datasets on drug supply and drug offences in the EU
  • Appendix C. Data collected about drug prices, purity and seizures in 3rd countries